Abstract
Despite high immunization rates with pertussis vaccines, clinical cases of pertussis have resurged in the United States. In the 1990s, acellular pertussis (aP) vaccines replaced whole-cell pertussis (wP) vaccines because of toxicity concerns. To assess whether the increase in pertussis cases is related to relatively lower efficacy of aP vaccines, FDA researchers compared infant baboons who had been immunized using either an aP and or a wP vaccine (at 2, …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
